Early Postoperative 1-Hour Outcomes Of A Novel Enhanced Monofocal Intraocular Lens With Intermediate Optimized Optics Implanted In Patients Undergoing Cataract Surgery
Published 2025 - 43rd Congress of the ESCRS
Reference: PO390 | Type: Free paper | DOI: 10.82333/679j-1392
Authors: Jose Aguilar-Falomir* 1 , Daniel Romero-Valero 1 , Cristian Fernández Martínez 1 , Carlos Monera Lucas 1 , Claudia Tarazona Jaimes 1
1Ophthalmology,General University Hospital of Elche,Elche,Spain
Purpose
To assess the early postoperative 1-hour visual acuity outcomes of a novel enhanced monofocal intraocular lens (IOL) implanted in patients undergoing cataract surgery. The new enhanced monofocal IOL consists of an intermediate 1.5 mm central zone, with a blend zone between the central and peripheral power, on the posterior surface of the lens that is designed to provide a gradual transition of incoming light.
Setting
Clinical data from patients who underwent cataract surgery with bilateral implantations with a novel enhanced monofocal IOL at the Surgical Eye Center Greensboro.
Methods
This prospective study included patients who underwent cataract surgery and implantation of a novel enhanced monofocal IOL (enVista ASPIRE™, Bausch & Lomb) that uses higher-order aspheric coefficients on the posterior surface to create a broad depth of focus. Outcome measures were binocular uncorrected distance (UDVA) and near (UNVA) visual acuity assessed at 1-hour following cataract surgery and IOL implantation. Data will be updated as enrollment progresses.
Results
Preliminary analysis (N = 50) showed that the median 1-hour UDVA was 0.994 decimal. At 1 hour following surgery UDVA was 20/25 or better in 88% of eyes, and 20/30 or better in 100% of eyes, respectively. At 1 hour postoperatively, 64% of eyes achieved a UNVA of 20/40 or better.
Conclusions
Following the implantation of a monofocal enVista ASPIRE™ IOL, the early postoperative 1-hour visual outcomes at distance and near were excellent.